Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes

Figure 2 The rates of strongly, moderately, and weakly positive and negative Ki-67 expression (%) in the three groups. Grey: Negative expression; Green: Weakly positive; Yellow: Moderately positive; Blue: Strongly positive. Group A: Patients with acute ischemic stroke (AIS) and type 2 diabetes mellitus; Group B: Patients with AIS alone; Group C: Patients with benign pulmonary lesions. ^aP < 0.05; ^bP < 0.01.